Navigation Links
ARAMARK Agrees to Sell its Galls Business to CI Capital Partners
Date:10/3/2011

PHILADELPHIA, Oct. 3, 2011 /PRNewswire/ -- ARAMARK, a global provider of professional services, announced today it has sold Galls, a leading provider of public safety equipment and apparel, to CI Capital Partners, a North American private investment firm. The terms of the transaction were not disclosed.  

(Logo: http://photos.prnewswire.com/prnh/20110907/PH63208LOGO)

Based in Lexington, Kentucky, Galls sells a wide variety of public safety products to leading law enforcement, fire and EMS agencies, private security companies and federal agencies so they can perform at their best.  

"Galls has earned its excellent reputation of providing public safety and emergency medical personnel with quality equipment and apparel and outstanding service," said Joseph Neubauer, Chairman and CEO of ARAMARK. "It has succeeded by continually anticipating the needs of customers and clients and by being dedicated to their success. This opportunity with CI Capital Partners enables Galls to pursue accelerated expansion and better positioning on which to grow and build its brand."

"We are very thrilled to complete a transaction that will provide Galls with the ability to continue its internal growth as well as pursue attractive acquisition opportunities. CI Capital has a long track record of growing distribution businesses and we are excited to build significant value at Galls," said Larry Dismukes, President of Galls.

About ARAMARK

ARAMARK is a leader in professional services, providing award-winning food servicesfacilities management, and uniform and career apparel to health care institutionsuniversities and school districtsstadiums and arenas, and businesses around the world. The company is recognized as one of the "World's Most Ethical Companies" by the Ethisphere Institute, as the industry leader in FORTUNE magazine's "World's Most Admired Companies," and as one of America's Largest Private Companies by both FORTUNE and Forbes magazines. ARAMARK seeks to responsibly address issues that matter to its clients, customers, employees and communities by focusing on employee advocacy, environmental stewardship, health and wellness, and community involvement. Headquartered in Philadelphia, ARAMARK has approximately 255,000 employees serving clients in 22 countries. Learn more at www.twitter.com/aramarknews.

About CI Capital Partners

CI Capital Partners is a North American private investment firm focused on building and expanding leading middle market businesses. The firm targets industries that are ripe for consolidation and seeks to substantially scale businesses through organic growth and acquisitions. Since its founding in 1993, the firm and its portfolio companies have made over 95 acquisitions repenting over $5 billion in enterprise value. CA Capital's existing portfolio consists of companies which collectively generate annual revenue of approximately $4.0 billion, EBITDA of $350 million and have more than 14,000 employees. To learn more, please visit www.cicapllc.com

Contact Information:

Sarah Jarvis, ARAMARK Communications
T: 215-238-7168
Jarvis-sarah@aramark.com


'/>"/>
SOURCE ARAMARK
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics
2. Valeant Pharmaceuticals Agrees to Acquire Dermik
3. BioMarin Agrees to Acquire Biologics Manufacturing Plant in Ireland from Pfizer
4. Devicor™ Medical Products, Inc. Agrees to Acquire Neoprobes Gamma Detection Devices
5. Biofield Corporations 51% Owned Subsidiary Agrees to Deal Appointing McKinley Infocapital as Korean Exclusive Distributor of Breast Cancer Diagnostic System; Contract has Potential Value of up to $15.3 Million
6. Quest Diagnostics Agrees to Repurchase 15.4 Million Shares From Largest Shareholder
7. Xanodyne Agrees to Withdraw Propoxyphene From the U.S. Market
8. Boston Scientific Agrees to Sell Neurovascular Business to Stryker
9. Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia
10. Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash
11. Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... PAUL, Minn. , July 20, 2017  Prime Therapeutics ... Jonathan Gavras , M.D., following today,s Institute for Clinical ... report on the effectiveness and value of abuse-deterrent ... manager on the policy roundtable at the meeting. ... is not a material cost benefit to the use of ...
(Date:7/14/2017)... It should come as no surprise to anyone that ... of a crippling opioid epidemic. According to the Center ... deaths from opiate-based medications has quadrupled, Says, Dr. David ... 2001 to 2015". During this time, the prescription rate for ... a compelling link between prescription and eventual addiction. The problem ...
(Date:7/12/2017)... , July 12, 2017  Eli Lilly and Company (NYSE: ... with generic companies to resolve pending patent litigation in the ... Virginia regarding the Cialis ® (tadalafil) unit ... April 26, 2020. As part of the agreement, Cialis exclusivity ... 27, 2018. "The unit dose patent for Cialis ...
Breaking Medicine Technology:
(Date:7/26/2017)... San Jose, Calif (PRWEB) , ... July 26, 2017 , ... Six greater Bay Area ... save lives with “Make ‘em Bleed,” the most widely attended series of blood drives in ... 900 units of blood over the past 4 years -- enough to have helped to ...
(Date:7/26/2017)... ... ... It may be hard to imagine that the basic necessities that developed countries ... that many developed countries consider rare or eradicated, like measles, are still a rite ... an upcoming segment of "Success Files", actor Rob Lowe will introduce a new segment ...
(Date:7/26/2017)... ... July 27, 2017 , ... It's time to sign up for the ... great benefits," says Kathy Heshelow, founder of Sublime Naturals and author of numerous books on ... oil each month, mailed by the 5th. , Two items are included ...
(Date:7/26/2017)... ... ... “We are thrilled to be partnering with Six Month Smiles to work ... in real time,” said Keith English, LocalMed CEO. “Allowing patients the ability to schedule ... Month Smiles patients to their providers.” , Each month, over 25,000 patients research Six ...
(Date:7/26/2017)... ... 26, 2017 , ... Isodiol International Inc. (CSE: ISOL) (OTC: ... the development of pharmaceutical and consumer products, announces the operational numbers of its ... Iso International LLC recorded unaudited fiscal Q1 profits of $897,596 based on revenues ...
Breaking Medicine News(10 mins):